Literature DB >> 1532309

The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is downregulated during cell growth and by transforming growth factor-beta.

G Ramadori1, K Neubauer, M Odenthal, T Nakamura, T Knittel, S Schwögler, K H Meyer zum Büschenfelde.   

Abstract

Hepatocyte growth factor (HGF) has been detected in non-parenchymal cells but not in hepatocytes. We performed Northern blot analysis of total RNA extracted from rat hepatocytes, Kupffer cells, endothelial cells and fat-storing (Ito-) cells. Total RNA was extracted from fat-storing cells at different times after isolation and from cells treated with different amounts of transforming growth factor beta. The RNA was hybridized with HGF, fibronectin-, and alpha-actin-specific cDNA probes, consecutively. We found an abundant amount of HGF mRNA in freshly isolated fat-storing cells, but not in other liver cells. The amount of the HGF transcripts decreases significantly in FSC during the time of culture, while fibronectin gene expression increases and alpha-actin gene expression as well. TGF-beta dramatically inhibits HGF gene expression, but causes an enhanced fibronectin mRNA level. Northern blot hybridisation of total RNA from CCl4-chronically damaged liver with HGF cDNA shows a significant increase of HGF mRNA during development of liver fibrosis. We suggest that in damaged liver either non-parenchymal cells, others than FSC, became able to express the HGF in vivo, or other mediators overcome the inhibitory effect of TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532309     DOI: 10.1016/0006-291x(92)90545-v

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

2.  Synaptophysin: A novel marker for human and rat hepatic stellate cells.

Authors:  D Cassiman; J van Pelt; R De Vos; F Van Lommel; V Desmet; S H Yap; T Roskams
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Authors:  A Kamiya; T Kinoshita; Y Ito; T Matsui; Y Morikawa; E Senba; K Nakashima; T Taga; K Yoshida; T Kishimoto; A Miyajima
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

4.  Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways.

Authors:  Jens U Marquardt; Daekwan Seo; Luis E Gómez-Quiroz; Koichi Uchida; Matthew C Gillen; Mitsuteru Kitade; Pal Kaposi-Novak; Elizabeth A Conner; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Biochim Biophys Acta       Date:  2012-02-22

5.  Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells.

Authors:  M Gallai; I Kovalszky; T Knittel; K Neubauer; T Armbrust; G Ramadori
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

6.  Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosis.

Authors:  Stephanie Schievenbusch; Ingo Strack; Melanie Scheffler; Roswitha Nischt; Oliver Coutelle; Marianna Hösel; Michael Hallek; Jochen W U Fries; Hans-Peter Dienes; Margarete Odenthal; Hildegard Büning
Journal:  Mol Ther       Date:  2010-04-27       Impact factor: 11.454

Review 7.  Hepatocyte growth factor/scatter factor-induced intracellular signalling.

Authors:  K A Stuart; S M Riordan; S Lidder; L Crostella; R Williams; G G Skouteris
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

8.  Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride.

Authors:  J J Maher
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Utility of Hepatocyte Growth Factor as a Biomarker for Early Diagnosis of Pulmonary Artery Hypertension.

Authors:  Mingting Liang; Ying Pang; Shuguang Zhang; Mei Zhang
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

10.  Foxl1 is a marker of bipotential hepatic progenitor cells in mice.

Authors:  Sara D Sackett; Zhaodong Li; Reginald Hurtt; Yan Gao; Rebecca G Wells; Karrie Brondell; Klaus H Kaestner; Linda E Greenbaum
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.